仙琚制药：取得贝前列素钠片境内生产药品注册证书

Core Viewpoint - Xianju Pharmaceutical (002332) has recently received the drug registration certificate for Beclomethasone Sodium Tablets from the National Medical Products Administration, indicating a significant regulatory approval for the company [1] Company Summary - The approved indication for Beclomethasone Sodium Tablets is to improve symptoms such as ulcers, intermittent claudication, pain, and cold sensation caused by chronic arterial occlusive disease [1]